We are live on ! Find out more
MC

Merlin Capital Portfolio holdings

AUM $33.5M
1-Year Est. Return 36.34%
This Fund
S&P 500
This Quarter Est. Return
+16.73%
1 Year Est. Return
+36.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$31.2M
AUM Growth
+$4.45M
Cap. Flow
+$179K
Cap. Flow %
0.57%
Top 10 Hldgs %
26.09%
Holding
57
New
2
Increased
20
Reduced
19
Closed
1

Top Buys

Rank Stock Value
1
DECK icon
Deckers Outdoor
DECK
+$576K
2
NTLA icon
Intellia Therapeutics
NTLA
+$239K
3
INCY icon
Incyte
INCY
+$207K
4
ALGM icon
Allegro MicroSystems
ALGM
+$180K
5
CSCO icon
Cisco
CSCO
+$51K

Top Sells

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$473K
2
PATH icon
UiPath
PATH
+$285K
3
MPWR icon
Monolithic Power Systems
MPWR
+$109K
4
NOW icon
ServiceNow
NOW
+$70K
5
PTC icon
PTC
PTC
+$60.1K

Sector Composition

Rank Sector Weight
1 Technology 52.81%
2 Consumer Discretionary 23.58%
3 Healthcare 10.88%
4 Communication Services 6.19%
5 Industrials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALGM icon
26
Allegro MicroSystems
ALGM
$8.72B
$613K 1.97%
20,261
+6,313
+45% +$180K
SWKS icon
27
Skyworks Solutions
SWKS
$9.54B
$591K 1.89%
5,253
+46
+0.9% +$4.5K
EXEL icon
28
Exelixis
EXEL
$14B
$590K 1.89%
24,583
-58
-0.2% -$1.26K
ADBE icon
29
Adobe
ADBE
$94.5B
$589K 1.89%
988
-11
-1% -$6.34K
MSFT icon
30
Microsoft
MSFT
$2.89T
$585K 1.88%
1,557
+4
+0.3% +$1.42K
LRCX icon
31
Lam Research
LRCX
$365B
$566K 1.81%
7,220
-80
-1% -$5.45K
V icon
32
Visa
V
$689B
$564K 1.81%
2,166
+9
+0.4% +$2.22K
CRSP icon
33
CRISPR Therapeutics
CRSP
$4.6B
$559K 1.79%
8,925
-167
-2% -$9.23K
INTC icon
34
Intel
INTC
$462B
$538K 1.73%
10,714
-291
-3% -$11.8K
SNPS icon
35
Synopsys
SNPS
$74.5B
$515K 1.65%
1,001
-95
-9% -$48.6K
TSLA icon
36
Tesla
TSLA
$1.22T
$510K 1.64%
2,054
+10
+0.5% +$2.38K
MU icon
37
Micron Technology
MU
$1.02T
$503K 1.61%
5,893
-84
-1% -$6.24K
TSM icon
38
TSMC
TSM
$2.07T
$502K 1.61%
4,827
-54
-1% -$5.15K
LITE icon
39
Lumentum
LITE
$55.4B
$487K 1.56%
9,295
+140
+2% +$6.1K
H icon
40
Hyatt Hotels
H
$18B
$455K 1.46%
3,488
– –
ACN icon
41
Accenture
ACN
$94.3B
$452K 1.45%
1,288
– –
MA icon
42
Mastercard
MA
$487B
$425K 1.36%
997
– –
CSCO icon
43
Cisco
CSCO
$452B
$422K 1.35%
8,358
+998
+14% +$51K
OTEX icon
44
Open Text
OTEX
$5.73B
$415K 1.33%
9,888
– –
NKE icon
45
Nike
NKE
$62.5B
$407K 1.3%
3,747
– –
HON icon
46
Honeywell
HON
$77.9B
$402K 1.29%
2,036
– –
UNH icon
47
UnitedHealth
UNH
$379B
$394K 1.26%
748
– –
FWONK icon
48
Liberty Media Series C
FWONK
$24.6B
$393K 1.26%
6,231
+555
+10% +$36.3K
TXN icon
49
Texas Instruments
TXN
$255B
$392K 1.26%
2,299
+13
+0.6% +$2.01K
INCY icon
50
Incyte
INCY
$23.7B
$230K 0.74%
+3,659
New +$207K
1
2
3

Similar funds

EFMFI
EnCap Flatrock Midstream Fund III San Antonio, Texas $40.6M AUM 26.14% 1-Year Est. Return
PHAM
Portland Hill Asset Management London, United Kingdom $40.9M AUM 39.27% 1-Year Est. Return
EFMFI
EnCap Flatrock Midstream Fund IV San Antonio, Texas $44M AUM 26.14% 1-Year Est. Return
OPPTF
OPSEU Pension Plan Trust Fund Toronto, Ontario, Canada $22.4M AUM 25.54% 1-Year Est. Return
PA
Pantechnicon Advisors London, United Kingdom $18.4M AUM 26.45% 1-Year Est. Return
LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
PML
Prime Movers Lab Jackson, Wyoming $13.5M AUM 0% 1-Year Est. Return
RCA
Reitz Capital Advisors Freeland, Michigan $55.6M AUM 12.74% 1-Year Est. Return

Merlin Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Merlin Capital held 57 positions worth $31.2M, up 17% from $26.8M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Merlin Capital's Q4 2023 filing shows 2 new, 20 increased, 19 reduced and 1 closed positions. Its largest new stake was Deckers Outdoor: 5,670 shares worth $632K. The largest sale was Warner Bros, an estimated $473K.

By sector, the portfolio is most concentrated in Technology at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Merlin Capital's largest Q4 2023 buy was Deckers Outdoor: 5,670 shares worth $632K.
  • Merlin Capital added most to Intellia Therapeutics in Q4 2023, an estimated $239K increase.
  • Merlin Capital's biggest Q4 2023 reduction was UiPath, cutting an estimated $285K.
  • Merlin Capital fully exited Warner Bros in Q4 2023, selling an estimated $473K.
  • Merlin Capital's ten largest holdings make up 26% of its $31.2M portfolio in Q4 2023.
  • Merlin Capital opened 2 new positions and closed 1 in Q4 2023.
  • Merlin Capital's portfolio value rose 17% quarter-over-quarter to $31.2M.

Based on Merlin Capital's 13F filing for Q4 2023, filed 5 Feb 2024.